$3.9998
0.7498[23.07%]
At close: Apr 11
$3.9998
0[0.00%]
After Hours: 8:23AM EDT
MEI Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of MEI Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | MEIP | Q3 | -$2.32 | -$1.52 | — | — | $5.89M | $40.00K | — | — | Get Alert |
02/13/2024 | PM | MEIP | Q2 | $1.40 | -$1.32 | -$1.66 | -25.76% | $32.73M | $100.00K | $0.00 | -100.00% | Get Alert |
11/09/2023 | PM | MEIP | Q1 | -$2.60 | -$2.12 | $8.46 | 499.06% | $8.73M | — | $65.30M | — | Get Alert |
09/26/2023 | PM | MEIP | Q4 | -$3.20 | -$2.41 | -$1.51 | 37.34% | $11.41M | $930.00K | $1.46M | 56.67% | Get Alert |
05/11/2023 | PM | MEIP | Q3 | -$3.20 | -$2.87 | -$2.32 | 19.16% | $9.69M | $460.00K | $5.89M | 1181.30% | Get Alert |
02/09/2023 | PM | MEIP | Q2 | -$1.80 | -$3.00 | $1.40 | 146.67% | $18.22M | $6.08M | $32.73M | 438.40% | Get Alert |
11/14/2022 | PM | MEIP | Q1 | -$3.60 | -$2.80 | -$2.60 | 7.14% | $13.39M | $5.90M | $8.73M | 47.97% | Get Alert |
09/08/2022 | PM | MEIP | Q4 | -$2.20 | -$3.80 | -$3.20 | 15.79% | $10.12M | $4.77M | $11.41M | 139.29% | Get Alert |
05/23/2022 | PM | MEIP | Q3 | -$5.60 | -$3.60 | -$3.20 | 11.11% | $2.42M | $3.44M | $9.69M | 181.80% | Get Alert |
02/10/2022 | PM | MEIP | Q2 | -$3.20 | -$4.00 | -$1.80 | 55.00% | $9.17M | $3.26M | $18.22M | 458.96% | Get Alert |
11/10/2021 | PM | MEIP | Q1 | -$2.60 | -$2.60 | -$2.60 | 0.00% | $3.83M | $12.26M | $13.39M | 9.19% | Get Alert |
09/02/2021 | PM | MEIP | Q4 | -$3.40 | -$3.40 | -$2.20 | 35.29% | $25.50M | $3.57M | $10.12M | 183.36% | Get Alert |
05/06/2021 | PM | MEIP | Q3 | -$2.20 | -$3.40 | -$5.60 | -64.71% | $1.24M | $5.18M | $2.42M | -53.32% | Get Alert |
02/04/2021 | PM | MEIP | Q2 | -$5.20 | — | -$3.20 | — | $1.01M | — | $9.17M | — | Get Alert |
11/10/2020 | PM | MEIP | Q1 | -$3.40 | — | -$2.60 | — | $1.16M | — | $3.83M | — | Get Alert |
09/09/2020 | PM | MEIP | Q4 | -$3.00 | — | -$3.40 | — | $1.13M | — | $25.50M | — | Get Alert |
05/07/2020 | AM | MEIP | Q3 | -$3.40 | — | -$0.80 | — | $1.25M | — | $1.24M | — | Get Alert |
02/06/2020 | PM | MEIP | Q2 | -$3.00 | — | -$5.20 | — | $2.05M | — | $1.01M | — | Get Alert |
11/07/2019 | PM | MEIP | Q1 | -$2.80 | — | -$0.80 | — | $488.00K | — | $1.16M | — | Get Alert |
MEI Pharma (MEIP) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on February 13, 2024 for Q2.
The Actual EPS was $-1.66, which missed the estimate of $-1.32.
The Actual Revenue was $0K, which missed the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.